Literature DB >> 12682119

Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria.

Ryousuke Yamano1, Masaru Ohara, Shuichi Nishikubo, Tamaki Fujiwara, Toru Kawamoto, Yoko Ueno, Hitoshi Komatsuzawa, Katsuji Okuda, Hidemi Kurihara, Hidekazu Suginaka, Eric Oswald, Kazuo Tanne, Motoyuki Sugai.   

Abstract

Cytolethal distending toxin (CDT) is a newly identified virulence factor produced by several pathogenic bacteria implicated in chronic infection. Seventy three strains of periodontopathogenic bacteria were examined for the production of CDT by a HeLa cell bioassay and for the presence of the cdt gene by PCR with degenerative oligonucleotide primers, which were designed based on various regions of the Escherichia coli and Campylobacter cdtB genes, which have been successfully used for the identification and cloning of cdtABC genes from Actinobacillus actinomycetemcomitans Y4 (M. Sugai et al., Infect. Immun. 66:5008-5019, 1998). CDT activity was found in culture supernatants of 40 of 45 tested A. actinomycetemcomintans strains, but the titer of the toxin varied considerably among these strains. PCR experiments indicated the presence of Y4-type cdt sequences in these strains, but the rest of A. actinomycetemcomitans were negative by PCR amplification and also by Southern blot analysis for the cdtABC gene. In the 40 CDT-positive strains, Southern hybridization with HindIII-digested genomic DNA revealed that there are at least 6 restriction fragment length polymorphism types. This suggests that the cdtABC flanking region is highly polymorphic, which may partly explain the variability of the CDT activity in the culture supernatants. The rest of tested strains of periodontopathogenic bacteria did not have detectable CDT production by the HeLa cell assay and for cdtB sequences by PCR analysis under our experimental conditions. These results strongly suggested that CDT is a unique toxin predominantly produced by A. actinomycetemcomitans among periodontopathogenic bacteria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682119      PMCID: PMC153874          DOI: 10.1128/JCM.41.4.1391-1398.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

Review 1.  Virulence factors of Actinobacillus actinomycetemcomitans.

Authors:  P M Fives-Taylor; D H Meyer; K P Mintz; C Brissette
Journal:  Periodontol 2000       Date:  1999-06       Impact factor: 7.589

2.  Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains.

Authors:  H J Ahmed; L A Svensson; L D Cope; J L Latimer; E J Hansen; K Ahlman; J Bayat-Turk; D Klamer; T Lagergård
Journal:  J Med Microbiol       Date:  2001-10       Impact factor: 2.472

Review 3.  Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation?

Authors:  J De Rycke; E Oswald
Journal:  FEMS Microbiol Lett       Date:  2001-09-25       Impact factor: 2.742

4.  Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells.

Authors:  B J Shenker; T McKay; S Datar; M Miller; R Chowhan; D Demuth
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

5.  Cytolethal distending toxin genes in Campylobacter jejuni and Campylobacter coli isolates: detection and analysis by PCR.

Authors:  A Eyigor; K A Dawson; B E Langlois; C L Pickett
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  Detection of cytolethal distending toxin activity and cdt genes in Campylobacter spp. isolated from chicken carcasses.

Authors:  A Eyigor; K A Dawson; B E Langlois; C L Pickett
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

7.  Prevalence of cytolethal distending toxin (cdt) genes and CDT production in Campylobacter spp. isolated from Danish broilers.

Authors:  Dang D Bang; Flemming Scheutz; Peter Ahrens; Karl Pedersen; Jens Blom; Mogens Madsen
Journal:  J Med Microbiol       Date:  2001-12       Impact factor: 2.472

8.  Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans.

Authors:  M P Mayer; L C Bueno; E J Hansen; J M DiRienzo
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

9.  Anti-proliferative and cytotoxic activity of surface-associated material from periodontopathogenic bacteria.

Authors:  S Meghji; M Wilson; B Henderson; D Kinane
Journal:  Arch Oral Biol       Date:  1992-08       Impact factor: 2.633

10.  Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes.

Authors:  D F Mangan; N S Taichman; E T Lally; S M Wahl
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more
  21 in total

1.  Immune response to cytolethal distending toxin of Aggregatibacter actinomycetemcomitans in periodontitis patients.

Authors:  E S Ando; L A De-Gennaro; M Faveri; M Feres; J M DiRienzo; M P A Mayer
Journal:  J Periodontal Res       Date:  2010-03-09       Impact factor: 4.419

2.  The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.

Authors:  G N Belibasakis; A Johansson; Y Wang; C Chen; S Kalfas; U H Lerner
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Differential effect of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans on co-cultures of human oral cells.

Authors:  Philip Kang; Jonathan Korostoff; Alla Volgina; Wojciech Grzesik; Joseph M DiRienzo
Journal:  J Med Microbiol       Date:  2005-08       Impact factor: 2.472

4.  Tissue destruction induced by Porphyromonas gingivalis infection in a mouse chamber model is associated with host tumor necrosis factor generation.

Authors:  Yuh-Yih Lin; Jan-Hung Huang; Yo-Yin Lai; Han-Ching Huang; Suh-Woan Hu
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice.

Authors:  A Izawa; Y Ishihara; H Mizutani; S Kobayashi; H Goto; E Okabe; H Takeda; Y Ozawa; Y Kamiya; Y Sugita; K Kubo; H Kamei; T Kikuchi; A Mitani; J Hayashi; T Nishihara; H Maeda; T Noguchi
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

Review 6.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.

Authors:  Rasika N Jinadasa; Stephen E Bloom; Robert S Weiss; Gerald E Duhamel
Journal:  Microbiology (Reading)       Date:  2011-05-12       Impact factor: 2.777

7.  Characterization of Aggregatibacter actinomycetemcomitans strains in periodontitis patients in Germany.

Authors:  Holger Jentsch; Georg Cachovan; Arndt Guentsch; Peter Eickholz; Wolfgang Pfister; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2012-01-14       Impact factor: 3.573

8.  Cytolethal distending toxin from Aggregatibacter actinomycetemcomitans induces DNA damage, S/G2 cell cycle arrest, and caspase- independent death in a Saccharomyces cerevisiae model.

Authors:  Oranart Matangkasombut; Roongtiwa Wattanawaraporn; Keiko Tsuruda; Masaru Ohara; Motoyuki Sugai; Skorn Mongkolsuk
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

9.  Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis.

Authors:  I Xynogala; A Volgina; J M DiRienzo; J Korostoff
Journal:  Oral Microbiol Immunol       Date:  2009-04

10.  Characterization of A. actinomycetemcomitans strains in subgingival samples from periodontitis subjects in Morocco.

Authors:  M Mínguez; O K Ennibi; X Pousa; L Lakhdar; L Abdellaoui; M Sánchez; M Sanz; D Herrera
Journal:  Clin Oral Investig       Date:  2015-11-23       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.